Invenomic Capital Management LP Psychemedics Corp Transaction History

Invenomic Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.1 - $7.04 $561,633 - $648,179	-92,071 Reduced 67.88%	43,560 $276,000
Q1 2022 May 16, 2022	BUY	$6.49 - $7.56 $59,409 - $69,204	9,154 Added 7.24%	135,631 $769,000
Q4 2021 Feb 11, 2022	BUY	$6.86 - $8.79 $7,971 - $10,213	1,162 Added 0.93%	126,477 $878,000
Q3 2021 Nov 15, 2021	BUY	$6.31 - $8.4 $86,200 - $114,752	13,661 Added 12.24%	125,315 $1.07 Million
Q2 2021 Aug 16, 2021	SELL	$6.25 - $8.25 $6,956 - $9,182	-1,113 Reduced 0.99%	111,654 $777,000
Q1 2021 May 13, 2021	SELL	$4.95 - $7.7 $103,187 - $160,514	-20,846 Reduced 15.6%	112,767 $699,000
Q4 2020 Feb 17, 2021	BUY	$3.67 - $5.1 $119,381 - $165,897	32,529 Added 32.18%	133,613 $680,000
Q3 2020 Nov 13, 2020	BUY	$4.33 - $6.05 $99,676 - $139,271	23,020 Added 29.49%	101,084 $446,000
Q2 2020 Aug 13, 2020	BUY	$4.9 - $6.14 $382,513 - $479,312	78,064 New	78,064 $430,000

1.24M

Ticker PMD
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 5,626,200
Market Cap $11.1M
Description
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Invenomic Capital Management LP with notifications on news.